rs587777709

Variant names:

• chr5-68293835-G-A
• rs587777709
• NM_181523.3:c.1425+1G>A

Your query was ambiguous. Multiple possible variants found:

• chr5-68293835-G-A
• chr5-68293835-G-C
• chr5-68293835-G-T

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_Moderate PM2 PP5_Very_Strong

The NM_181523.3(PIK3R1):​c.1425+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

• Frequency: Genomes: not found (cov: 32)
• Consequence: PIK3R1 NM_181523.3 splice_donor, intron
• Scores: Splicing: ADA: 1.000
• Clinical Significance: Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:13 O:1
• Conservation: PhyloP100: 9.35

Genes affected

PIK3R1 (HGNC:8979): (phosphoinositide-3-kinase regulatory subunit 1) Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. This gene encodes the 85 kD regulatory subunit. Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance. Alternative splicing of this gene results in four transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]

ACMG classification

Verdict is Pathogenic. Variant got 12 ACMG points.

• PVS1: Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.057931036 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 5-68293835-G-A is Pathogenic according to our data. Variant chr5-68293835-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 372467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-68293835-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
PIK3R1	NM_181523.3	c.1425+1G>A		splice_donor_variant, intron_variant	Intron 11 of 15	ENST00000521381.6	NP_852664.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
PIK3R1	ENST00000521381.6	c.1425+1G>A		splice_donor_variant, intron_variant	Intron 11 of 15	1	NM_181523.3	ENSP00000428056.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Cov.: 27

GnomAD4 genome Cov.: 32

ClinVar

Significance: Pathogenic/Likely pathogenic

Submissions summary: Pathogenic:13 Other:1

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Pathogenic:3 Other:1

Dec 07, 2016

GeneDx

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The c.1425+1G>A pathogenic variant has been reported previously in association with PASLI disease (Lucas et al., 2014). cDNA studies indicated that c.1425+1G>A results in the skipping of exon 11 (Lucas et al., 2014). This splice site variant destroys the canonical splice donor site in intron 11. It is predicted to cause abnormal gene splicing, either leading to an abnormal message that is subject to nonsense mediated mRNA decay, or to an abnormal protein product if the message is used for protein translation. The c.1425+1G>A variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, we interpret this variant to be pathogenic. -

Oct 19, 2018

Blueprint Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Dec 01, 2024

CeGaT Center for Human Genetics Tuebingen

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

PIK3R1: PM6:Strong, PM2, PS4:Moderate, PP3, PS3:Supporting -

-

MutSpliceDB: a database of splice sites variants effects on splicing, NIH

Significance: not provided

Review Status: no classification provided

Collection Method: research

- -

SHORT syndrome Pathogenic:3

Feb 21, 2020

Baylor Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jul 27, 2022

Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence variant is a single nucleotide substitution (G>A) at the +1 position downstream of the exon 11 canonical splice donor site of the PIK3R1 gene. This is a previously reported variant (ClinVar) which has been observed as a de novo variant in multiple individuals with a combition of phenotypes including short stature, immunodeficiency, hyper IgM syndrome, and hyperactivation of PI3K and AKT (PMID: 28302518, 27076228, 27693481, 25939554, 25488983, 27116393). This variant is not present in approximately 210300 alleles in the gnomAD control population dataset. Splicing studies show that this variant leads to an in-frame deletion of exon 11 (PMID: 25488983, 27076228); the variant protein is constitutively active, due to its ibility to properly interact with p110delta (PMID: 25488983). Based on the available evidence, we consider this variant to be pathogenic. ACMG Criteria: PM1, PM2, PM4, PP3, PP4, PS2, PS3, PS4 -

May 28, 2019

Mendelics

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

SHORT syndrome;C3554689:Agammaglobulinemia 7, autosomal recessive;C4014934:Immunodeficiency 36 Pathogenic:2

Mar 22, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change affects a donor splice site in intron 11 of the PIK3R1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with hypogammaglobulinemia with elevated IgM, activated PI3K-delta syndrome, and SHORT syndrome (PMID: 25488983, 25939554, 27076228, 27116393, 27693481, 28302518). In at least one individual the variant was observed to be de novo. This variant is also known as g.67589663G>A. ClinVar contains an entry for this variant (Variation ID: 372467). Studies have shown that disruption of this splice site results in skipping of exon 11, but is expected to preserve the integrity of the reading-frame (PMID: 27076228). For these reasons, this variant has been classified as Pathogenic. -

Mar 29, 2022

Fulgent Genetics, Fulgent Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

PIK3R1-related disorder Pathogenic:1

Jan 11, 2024

PreventionGenetics, part of Exact Sciences

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

The PIK3R1 c.1425+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported as a recurrent de novo mutation in multiple individuals with activated phosphoinositide 3-kinase δ syndrome type 2 (APDS2) (Lucas et al. 2014. PubMed ID: 25488983; Lougaris et al. 2015. PubMed ID: 25939554; Petrovski et al. 2016. PubMed ID: 27076228; Olbrich et al. 2016. PubMed ID: 27116393; Elkaim et al. 2016. PubMed ID: 27221134; Yazdani et al. 2019. PubMed ID: 30799802). RNA analysis has shown that this variant leads to an in-frame deletion of 42 amino acid residues, and in vitro functional studies using tranformed patient B cells have shown that this deletion leads to reduced p85α protein expression, constitutive activation of the PI3K complex, and upregulation of downstream AKT and mTOR signaling pathways (Petrovski et al. 2016. PubMed ID: 27076228). This variant has not been reported in a large population database, indicating this variant is rare. Several additional variants that disrupt the same splice donor site (c.1425+1G>C/T, +2T>A/G, +2_+3delTG, etc.) have been reported in multiple individuals with ADPS-related phenotypes (Deau et al. 2014. PubMed ID: 25133428; Elkaim et al. 2016. PubMed ID: 27221134). Variants that disrupt the consensus splice donor site in PIK3R1 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Inborn genetic diseases Pathogenic:1

Dec 15, 2017

Ambry Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

See cases Pathogenic:1

Dec 21, 2022

Center for Personalized Medicine, Children's Hospital Los Angeles

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Inherited Immunodeficiency Diseases Pathogenic:1

Jan 01, 2019

NIHR Bioresource Rare Diseases, University of Cambridge

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: research

- -

Immunodeficiency 36 Pathogenic:1

Mar 15, 2023

OMIM

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.63	D
BayesDel_noAF	Pathogenic	0.41
CADD	Pathogenic	34
DANN	Uncertain	1.0
Eigen	Pathogenic	1.2
Eigen_PC	Pathogenic	1.1
FATHMM_MKL	Pathogenic	1.0	D
GERP RS		5.1

Splicing

Name	Calibrated prediction	Score	Prediction
dbscSNV1_ADA	Pathogenic	1.0
dbscSNV1_RF	Pathogenic	0.94
SpliceAI score (max)		0.99		Details are displayed if max score is > 0.2
DS_DL_spliceai		0.99		Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs587777709; hg19: chr5-67589663; COSMIC: COSV57123381; COSMIC: COSV57123381;